Cystic Fibrosis
Roderic J. Phillips
Royal Children's Hospital, Melbourne, Australia
Search for more papers by this authorRoderic J. Phillips
Royal Children's Hospital, Melbourne, Australia
Search for more papers by this authorPeter Hoeger
Search for more papers by this authorVeronica Kinsler
Search for more papers by this authorAlbert Yan
Search for more papers by this authorJohn Harper
Search for more papers by this authorArnold Oranje
Search for more papers by this authorChristine Bodemer
Search for more papers by this authorMargarita Larralde
Search for more papers by this authorVibhu Mendiratta
Search for more papers by this authorDiana Purvis
Search for more papers by this authorSummary
Cystic fibrosis is characterized by dysfunction of lungs, pancreas, skin and other organs. In some ethnic groups, it is the most common potentially lethal autosomal recessive disorder. In countries where neonatal screening for cystic fibrosis is routine, clinical problems can be anticipated and largely avoided. In other countries, one initial presentation of the disease may be in infancy with failure to thrive, oedema and well-demarcated, erythematous, scaly plaques covering most of the body. This presentation is related to kwashiorkor secondary to malabsorption and responds to pancreatic enzyme replacement. In older children, aquagenic wrinkling of palms can be seen in some children with cystic fibrosis and also in normal children. With current management protocols for cystic fibrosis, the life expectancy is now expected to be greater than 50 years.
References
- Riordan JR, Rommens JM, Kerem B et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066–73.
- Cystic fibrosis mutations database at http://www.genet.sickkids.on.ca/.
- O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009; 373: 1891–904.
- Nielsen OH, Larsen BF. The incidence of anaemia, hypoalbuminaemia and oedema in infants as presenting symptoms of cystic fibrosis: a retrospective survey of the frequency of this symptom complex in 130 patients with cystic fibrosis. J Paediatr Gastroenterol Nutr 1982; 1: 355–9.
- VanDevanter DR, Kahle JS, O'Sullivan AK et al. Cystic fibrosis in young children: a review of disease manifestation, progression, and response to early treatment. J Cyst Fibros 2016; 15: 147–57.
- Turner MA, Baildam E, Patel L et al. Joint disorders in cystic fibrosis. J Roy Soc Med 1997; 90(suppl 31): 13–20.
- Mickle JE, Macek M, Fulmer-Smentek SB et al. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Hum Mol Genet 1998; 7: 729–35.
- Urbatsch A, Paller AS. Pustular miliaria rubra: a specific cutaneous finding of type 1 pseudohypoaldosteronism. Pediatr Dermatol 2002; 19: 317–19.
- Crone J, Huber W-D, Eichler I et al. Acrodermatitis enteropathica-like eruption as the presenting sign of cystic fibrosis – case report and review of the literature. Eur J Pediatr 2002; 161: 475–8.
- Phillips RJ, Crock CM, Dillon MJ et al. Cystic fibrosis presenting as kwashiorkor with florid skin rash. Arch Dis Child 1993; 69: 446–8.
- Dodge JA, Salter DG, Yassa JG. Essential fatty acid deficiency due to artificial diet in cystic fibrosis. BMJ 1975; 2(5964): 192–3.
- Darmstadt GL, McGuire J, Ziboh VA. Malnutrition-associated rash of cystic fibrosis. Pediatr Dermatol 2000; 17: 337–47.
- Hansen RC, Lemen R, Revsin B. Cystic fibrosis manifesting with acrodermatitis enteropathica-like eruption. Arch Dermatol 1983; 119: 51–5.
- Mazzocchi C, Michel JL, Chalencon V et al. Zinc deficiency in mucoviscidosis. Arch Pediatrie 2000; 7: 1081–4.
- Patrizi A, Bianchi F, Neri I, Specchia F. Acrodermatitis enteropathica like eruption: a sign of malabsorption in cystic fibrosis. Pediatr Dermatol 2003; 20: 187–8.
- Muniz AE, Bartle S, Foster R. Edema, anemia, hypoproteinemia, and acrodermatitis enteropathica: an uncommon initial presentation of cystic fibrosis. Pediatr Emerg Care 2004; 20: 112–14.
- Martin DP, Tangsinmankong N, Sleasman JW et al. Acrodermatitis enteropathica-like eruption and food allergy. Ann Allergy Asthma Immunol 2005; 94: 398–401.
- Hussain W, Craven N, Swann I. An unwell child with a florid rash. Arch Dis Child 2005; 90: 1287.
- O'Regan GM, Canny G, Irvine AD. ‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis. J Cystic Fibrosis 2006; 5: 257–9.
- Lovett A, Kokta V, Maari C. Diffuse dermatitis: an unexpected initial presentation of cystic fibrosis. J Am Acad Dermatol 2008; 58: S1–4.
- Zedek D, Morrell DS, Graham M et al. Acrodermatitis enteropathica-like eruption and failure to thrive as presenting signs of cystic fibrosis. J Am Acad Dermatol 2008; 58: S5–8.
- Koch LH, Lewis DW, Williams JV. Necrolytic migratory erythema like presentation for cystic fibrosis. J Am Acad Dermatol 2008; 58: S29–30.
- Pekcan S, Kose M, Dogru D et al. A 4-month-old boy with acrodermatitis enteropathica-like symptoms. Eur J Pediatr 2009; 168: 119–21.
- Wenk KS, Higgins KB, Greer KE. Cystic fibrosis presenting with dermatitis. Arch Dermatol 2010; 146: 171–4.
- Seitz CS, Gaigl Z, Brocker EB, Trautmann A. Painful wrinkles in the bathtub: association with hyperhidrosis and cystic fibrosis. Dermatology 2008; 21: 222–6.
- Berk DR, Ciliberto HM, Sweet SC et al. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations. Arch Dermatol 2009; 145: 1296–9.
- Phillips R. Aquagenic palmoplantar keratoderma: a new sign of cystic fibrosis? Br J Dermatol 2011; 164: 224–5.
- Bhojani S, Sriskandan S, Bush A. Aquagenic wrinkling of palms on exposure to alcohol gel. Pediatr Pulmonol 2001; 46: 98–9.
- Spigarelli MG, Hurwitz ME, Nasr SZ. Hypersensitivity to inhaled TOBI following reaction to gentamicin. Pediatr Pulmonol 2002; 33: 311–14.
- Finnegan MJ, Hinchcliffe J, Russell-Jones D et al. Vasculitis complicating cystic fibrosis. Q J Med New Series 72 1989; 267: 609–21.
-
Jaffe A, Bush A. If you can't stand the rash, get out of the kitchen: an unusual adverse reaction to ciprofloxacin. Pediatr Pulmonol 1999; 28: 449–50.
10.1002/(SICI)1099-0496(199912)28:6<449::AID-PPUL11>3.0.CO;2-H CAS PubMed Web of Science® Google Scholar
- Vaze D. Episodic arthritis in cystic fibrosis. J Pediatr 1980; 96: 346.
- Warner JO, Taylor BW, Norman AP et al. Association of cystic fibrosis with allergy. Arch Dis Child 1976; 51: 507–11.
- Laufer P, Fink JN, Bruns WT et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984; 73: 44–8.
- Greally P, Cook AJ, Sampson AP et al. Atopic children with cystic fibrosis have increased urinary leukotriene E4 concentrations and more severe pulmonary disease. J Allergy Clin Immunol 1994; 93: 100–7.
- Laufer P. Urticaria in cystic fibrosis. Cutis 1985; 36: 245–6.
- Lewis MB. Rothmund–Thompson syndrome and fibrocystic disease. Aust J Dermatol 1972; 13: 105.
- Laufer P, Laufer R. Solar urticaria in cystic fibrosis. Cutis 1983; 31: 665–6.
- Pruszewicz A, Sokolowski Z, Goncarzewicz A. Mucoviscidosis coexisting with generalised albinism. Otolaryngol Polska 1978; 32: 93–5.
- Rivilla F, Lopez J. Meconium ileus equivalent and Kawasaki syndrome. Eur J Surg 1991; 157: 151–2.
- Ciofu C, Laky D, Geormaneanu M. Kawasaki disease in an infant with cystic fibrosis. Rom J Morph Embryol 1992; 38: 63–6.
- Nielsen HE, Lundh S, Jacobsen SV et al. Hypergammaglobulinemic purpura in cystic fibrosis. Acta Paediatr Scand 1978; 67: 443–7.
- Soter NA, Mihm MC, Colten HR. Cutaneous necrotizing venulitis in patients with cystic fibrosis. J Pediatr 1979; 95: 197–201.
- Mascaro JM, Ferrando J, Bombi JA et al. Congenital generalised follicular hamartoma associated with alopecia and cystic fibrosis in three siblings. Arch Dermatol 1995; 131: 454–8.
- Zedek D, Morrell DS, Graham M et al. Acrodermatitis enteropathica-like eruption and failure to thrive as presenting signs of cystic fibrosis. J Am Acad Dermatol 2008; 58: S5–8.
- Phillips RJ. Malabsorption-related rash in cystic fibrosis does not portend a poor prognosis. J Am Acad Dermatol 2008; 59: 720.
- Massie J. Re: Acrodermatitis enteropathica-like eruption and failure to thrive as presenting signs of cystic fibrosis. J Am Acad Dermatol 2008; 59: 720–1.
- Quon BS, Rowe SM. New and emerging targeted therapies for cystic fibrosis. BMJ 2016; 352: i859.
- Spigarelli MG, Hurwitz ME, Nasr SZ. Hypersensitivity to inhaled TOBI following reaction to gentamicin. Pediatr Pulmonol 2002; 33: 311–14.
- Perera E, Massie J, Phillips RJ. Treatment of acne with oral isotretinoin in patients with cystic fibrosis. Arch Dis Child 2009; 94: 583–6.
- Feranchak AP, Sontag MK, Wagener JS et al. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr 1999; 135: 601–10.
- Neugebauer MA, Vernon SA, Brimlow G et al. Nyctalopia and conjunctival xerosis indicating vitamin A deficiency in cystic fibrosis. Eye 1989; 3: 360–4.
- Welsh BM, Smith AL, Elder JE et al. Night blindness precipitated by isotretinoin in the setting of hypovitaminosis A. Aust J Dermatol 1999; 40: 208–10.
- Buckley JL, Chastain M, Rietschel R. Improvement of cystic fibrosis during treatment with isotretinoin. SKINmed 2006; 5: 252–5.